Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2015 Feb;13(2):177-83.

Institutional review of compliance with NCCN guidelines for breast cancer: lessons learned from real-time multidimensional synoptic reporting.

Author information

1
From the Department of Surgery, Department of Medical Education, Norma J. Vinger Center for Breast Care, Department of Pathology, Department of Medical Oncology, Department of Radiation Oncology, Department of Research, Department of Clinical Data Services, and Department of Hematology, Gundersen Health System, La Crosse, Wisconsin. From the Department of Surgery, Department of Medical Education, Norma J. Vinger Center for Breast Care, Department of Pathology, Department of Medical Oncology, Department of Radiation Oncology, Department of Research, Department of Clinical Data Services, and Department of Hematology, Gundersen Health System, La Crosse, Wisconsin.
2
From the Department of Surgery, Department of Medical Education, Norma J. Vinger Center for Breast Care, Department of Pathology, Department of Medical Oncology, Department of Radiation Oncology, Department of Research, Department of Clinical Data Services, and Department of Hematology, Gundersen Health System, La Crosse, Wisconsin.

Abstract

BACKGROUND:

Variations exist in compliance with NCCN Guidelines. Prior reports of adherence to NCCN Guidelines contain limitations because of lack of contemporary review and incomplete listing of reasons for noncompliance.

PURPOSE:

To assess institutional compliance and assist national quality improvement strategies through identifying valid reasons for noncompliance.

METHODS:

Compliance with NCCN Guidelines was recorded prospectively using electronic synoptic templates for patients with newly diagnosed breast cancer treated at a single institution between January 2010 and December 2011. Compliance with NCCN Guidelines was recorded. The accuracy of real-time synoptic auditing methods compared with retrospective chart review and reasons for noncompliance was assessed. SAS 9.3 software was used for data analysis.

RESULTS:

Compliance with NCCN Guidelines among 395 patients was 94% for initial staging evaluation, 97% for surgery, 91% for chemotherapy, 89% for hormone therapy, 91% for radiation therapy, 85% for follow-up, and 100% for determination of estrogen receptor/progesterone receptor and HER2 status. Age, comorbidities, and stage influenced guideline compliance. The most common reasons for noncompliance were patient refusal, patient choice after shared decision-making, and overuse of testing. Synoptic templated reporting was accurate in 97% patients.

CONCLUSIONS:

High compliance with NCCN Guidelines was demonstrated. Reasons for noncompliance were identifiable. Compliance and nonadherence can be evaluated quickly with electronic synoptic reporting. This allows real-time action plans to address quality concerns and aids national risk adjustment for comparison and benchmarking.

PMID:
25691610
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center